These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8434380

  • 1. Diltiazem in renal allograft recipients receiving cyclosporine.
    Chrysostomou A, Walker RG, Russ GR, d'Apice AJ, Kincaid-Smith P, Mathew TH.
    Transplantation; 1993 Feb; 55(2):300-4. PubMed ID: 8434380
    [Abstract] [Full Text] [Related]

  • 2. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 3. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A, Sumethkul V, Chalermsanyakorn P, Jirasiritham S.
    J Med Assoc Thai; 2006 Aug 15; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [Abstract] [Full Text] [Related]

  • 4. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome.
    Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL.
    Transplantation; 1994 Mar 27; 57(6):889-92. PubMed ID: 8154037
    [Abstract] [Full Text] [Related]

  • 5. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients.
    Xue W, Ding X, Tian P, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X.
    Ren Fail; 2010 Jan 27; 32(3):314-9. PubMed ID: 20370446
    [Abstract] [Full Text] [Related]

  • 7. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.
    Eisen HJ, Hobbs RE, Davis SF, Laufer G, Mancini DM, Renlund DG, Valantine H, Ventura H, Vachiery JL, Bourge RC, Canver CC, Carrier M, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Master R, Michaud JL, Paradis I, Smith A, Vanhaecke J, Mueller EA.
    Transplantation; 1999 Sep 15; 68(5):663-71. PubMed ID: 10507486
    [Abstract] [Full Text] [Related]

  • 8. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study.
    Ladefoged SD, Pedersen E, Hammer M, Rasmussen KC, Hansen FM, Andersen CB.
    Nephrol Dial Transplant; 1994 Sep 15; 9(5):543-7. PubMed ID: 8090335
    [Abstract] [Full Text] [Related]

  • 9. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
    Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, Campistol JM, Morales JM, Grinyo JM, Mourad G, Berthoux FC, Brattström C, Lebranchu Y, Vialtel P.
    Transplantation; 2000 Apr 15; 69(7):1252-60. PubMed ID: 10798738
    [Abstract] [Full Text] [Related]

  • 10. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation.
    Valantine H, Keogh A, McIntosh N, Hunt S, Oyer P, Schroeder J.
    J Heart Lung Transplant; 1992 Apr 15; 11(1 Pt 1):1-7; discussion 7-8. PubMed ID: 1540597
    [Abstract] [Full Text] [Related]

  • 11. Protective effects of calcium antagonists in human renal transplantation.
    Neumayer HH, Kunzendorf U, Schreiber M.
    Kidney Int Suppl; 1992 May 15; 36():S87-93. PubMed ID: 1377295
    [Abstract] [Full Text] [Related]

  • 12. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
    Baboolal K.
    Transplantation; 2003 Apr 27; 75(8):1404-8. PubMed ID: 12717239
    [Abstract] [Full Text] [Related]

  • 13. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L, Ding T, Wang XX, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681
    [Abstract] [Full Text] [Related]

  • 14. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR, Gaber AO, Haag BW, Aronson AJ, Broelsch CE, Stuart JK, Stuart FP.
    Transplantation; 1987 Feb 31; 43(2):176-84. PubMed ID: 3544373
    [Abstract] [Full Text] [Related]

  • 15. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
    Suthanthiran M, Haschemeyer RH, Riggio RR, Adubor C, Friedman GS, Cheigh JS, Wang JC, Fotino M, Stubenbord WT, Saal SD.
    Transplantation; 1993 May 31; 55(5):1008-13. PubMed ID: 8497873
    [Abstract] [Full Text] [Related]

  • 16. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 31; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 17. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
    Briggs D, Dudley C, Pattison J, Pfeffer P, Salmela K, Rowe P, Tydén G, European Tacrolimus Renal Rejection Study Group.
    Transplantation; 2003 Jun 27; 75(12):2058-63. PubMed ID: 12829912
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 20. Effect of OKT3 in steroid-resistant renal transplant rejection.
    Petrie JJ, Rigby RJ, Hawley CM, Suranyi MG, Whitby M, Wall D, Hardie IR.
    Transplantation; 1995 Feb 15; 59(3):347-52. PubMed ID: 7871563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.